Skip to main content
. 2021 Sep 14;6(2):270–280. doi: 10.1002/hep4.1820

TABLE 1.

Clinical Characteristics of All Patients

Characteristic All Patients
n = 27 (100%)
Baseline and demographics
Age (years), mean (range) 59 (20‐80)
Sex 7 females
20 males
BMI, mean (range) 27.3 (21.5‐37.7)
Comorbidities
Obesity (%) 7 (25.9)
DM (%) 6 (22.2)
Symptoms and hospital course
O2 saturation at admission 94 (69‐100)
Supplemental O2 (%) 27 (100)
Invasive mechanical ventilation 23 (85.2)
Previous medications received
ACE inhibitor 6 (22.2)
Captopril 5 (18.5)
Enalopril/hydrochlorothiazide 1 (3.7)
Antiarrhythmic
Amiodarone 1 (3.7)
Antibiotics
Amoxicillin 2 (7.4)
Azithromycin 15 (55.5)
Ceftriaxone 20 (74.1)
Cephalexin 1 (3.7)
Cephepime 1 (3.7)
Clarithromycin 6 (22.2)
Clindamycin 1 (3.7)
Piperacillin/tazobactam 1 (3.7)
Vancomycin 1 (3.7)
Antiretrovirals 0 (0)
Immunobiologics 0 (0)
Bronchodilators (fenoterol, ipratropium, aminophylline) 1 (3.7)
Ibuprofen 1 (3.7)
Statin (simvastatin) 1 (3.7)
Steroids (hydrocortisone) 1 (3.7)
Medications received during day 1
ACE inhibitor (captopril) 2 (7.4)
Antibiotics 27 (100)
Amoxicillin 0 (0)
Azithromycin 22 (81.5)
Ceftriaxone 0 (0)
Cephalexin 0 (0)
Cephepime 0 (0)
Clarithromycin 4 (14.8)
Clindamycin 1 (3.7)
Piperacillin/tazobactam 1 (3.7)
Vancomycin 0 (0)
Anticoagulation 18 (66.7)
Enoxaparin 15 (55.5)
Heparin 4 (14.8)
Antivirals (Tamiflu) 22 (81.5)
Bronchodilators 0 (0)
Insulin 3 (11.1)
Steroids 4 (14.8)
Hydrocortisone 2 (7.4)
Prednisone 1 (3.7)
Methylprednisone 1 (3.7)
Vasopressors 14 (51.8)
Dobutamine 0 (0)
Dopamine 0 (0)
Norepinephrine 14 (51.8)
Laboratory values, mean (range)/number
AST (units/L) 92.2 (29.3‐343)/13
ALT (IU/L) 100.61 (22.1‐533.3)/15
Total bilirubin (mg/dL) 1.13 (0.15‐3.08)/14
Hemoglobin (g/dL) 11.0 (6.2‐14.5)/27
Platelets (103/μL) 217.8 (25‐437)/27
Leukocytes (103/μL) 12.4 (5.2‐32.0)/27
Creatinine (mg/dL) 3.7 (0.63‐16.3)/27